PhRMA Jumps Into Battle Over Mifepristone Regulation With Supreme Court Filing

 
• By Brenda Sandburg
  
Court Ruling
PhRMA expresses concern about an ‘unprecedented assault on FDA’s approval decisions.’ • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership